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Two siblings presented with a new phenotype consisting 
of fatal progressive macrocephaly and hypertrophic car­
diomyopathy. Onset of symptoms started in both pa­
tients at the end of the first month of life with massive 
brain swelling causing macrocephaly and evolving to ex­
tensive brain destruction. Light microscopy of the lesions 
showed extensive small-vessel proliferation and gliosis. A 
distinct deficiency of complex I of mitochondrial respira­
tory chain was established in cultured fibroblasts, skeletal 
muscle, and heart muscle. Specific lack of complex I pro­
tein was demonstrated by two-dimensional gel electro­
phoresis.
Dionisi-Vici C, Ruitenbeek W, Fariello G, Bentlage H, 
Wanders RJA, Schiigger H, Bosman C, Piantadosi C, 
Sabetta G, Bertini E. New familial mitochondrial 
encephalopathy with macrocephaly, cardiomyopathy, and 
complex I deficiency. Ann Neurol 1997:42:661
»lí---<|-.|"»'--II—~-v*-. .  x i . I  V i .  A i J i i i U - l . ' . ‘i * ~ i - . i ' ‘. ' 1  r . * .  « I  * i ’ * - V  * * * '  I  ........ '  '  a * ' * * .  1 •  1 r ^ r n  —  ^ * i *  . a * . *  —  _ ; » v . w  .  % . .  - i -  ■ . . c v r  '  ■ < • ! <  *  h  <* *
10. Canadian Study of Health and Aging Working Group. Cana­
dian Study o f  Health and Aging: study methods and prevalence 
ol dementia. Clan Med Assoc J 1994;150:899-912
11. Hixson J, Vernier D. Restriction isotyping of human apoli- 
poprotein E by gene amplification and cleavage with HliAI. J
Lipid Res 1991;31:545-548
12. Corder Mi l, Saunders AM, Risch NJ, et al. Protective effect of  
apolipoprotein E type 2 allele for late-onset Alzheimer disease. 
Nat Genet 1994:7:180-184
13. Kamboli MI, Sepehmia B, Ferrell RE. Genetic studies ol hu­
man apolipoproteins. VI. Common polymorphism of apoli­
poprotein E in blacks. Dis Markers 1989:7:49—55
Pure complex I deficiency of the mitochondrial respi­
ratory chain is associated with either a myopathic or a 
multisystem disorder [1]. The latter has 
classified into different clinical groups including a fatal 
infantile phenotype, a second phenotype with milder 
encephalopathy and multiorgan dysfunction, and a
in some cases with maternally inher­
ited mitochondrial encephalomyopathy, lactic acidosis, 
and stroke-like episodes (MKLAS) syndrome. In some 
kindreds there was consanguinity suggesting an autoso-
' t  ■ ,  -  i  *1 .  * » .  . • ' . . . .  .  > .  > -  ,  I - * - * . . .  j !  ~ - •  I  . . .  I . * . . - . .  .  :  ......................'  ,  ,  . 1  M
From ^Bambino Gesù Hospital* Rome, Italy; ’(’Department o f  Pe­
diatrics, University Hospital, Nijmegen, and $ Department of Pedi­
atrics, University Hospital, Amsterdam, The Netherlands; and 
§Center o f  Biological Chemistry, University Hospital, Frankfurt, 
Germany.
Received Oct 25, 1996, and in revised form Apr 24, 1997. Ae» 
cep ted for publication Apr 24, 1997.
Address correspondence to Dr Dionisi-Vici, Department of Metab­
olism, Bambino Gesù Children’s Hospital, IRCCS, Piazza S. Ono-
(rio 4, 1-00165» Rome, Italy.
Copyright ©  1997 by the American Neurological Association 661
mal recessive inheritance. However, most cases appear 
to be sporadic [1],
We describe a new phenotype in 2 siblings with fatal 
infantile progressive macrocephaly, hypertrophic car­
diomyopathy, lactic acidosis, and complex I deficiency.
with succinate dehydrogenase (SDH) histochemistry and no 
ragged-red fibers, using modified Gomori’s trichrome stain. 
There was no evidence of lipid and glycogen accumulation. 
Polymerase chain reaction analysis of mtDNA for the most 
well-known point mutations and deletions were negative and 
the sequence of whole tRNA1'“1 was normal.
Patients and M ethods
Patient 1
The proband, a boy, was the second child of healthy unre­
lated Italian parents. The mother was gravida 2, para 2. He 
was born by cesarean section after an uncomplicated full- 
term pregnancy. Birth weight was 2,570 g (third percentile), 
length 48 cm (third percentile), and head circumference 33.5 
cm (third percentile). The neonatal period was uneventful.
At the age of 2 months he was hospitalized because of 
developmental delay and progressive irritability. He was mac- 
rocephalic with an enlarged and bossing anterior fontanel, 
head circumference was 45 cm (above the 97th percentile). 
Limbs were hypertonic and axial tone was reduced, tendon 
reflexes were brisk. Funduscopy and electroencephalography 
were normal.
Persistent elevation o f blood lactate (range, 8 -1 3  mmol/L; 
normal, 0 .6 -2  mmol/L), metabolic acidosis (pH 7.27; base 
excess, —10.7 mmol/L), and elevated plasma alanine (650 
|xmol/L; normal, 2 5 0 -4 5 0  (xmol/L) were detected. Cerebro­
spinal fluid lactate (17 mmol/L; normal, 0 .6 -2  mmol/L) was 
elevated. Serum levels of creatine kinase, transaminases, glu-
ammonia were normal. Urinary organic acidsandcose,
showed increased excretion o f lactate and Krebs cycle inter­
mediates.
Brain magnetic resonance imaging (MRI) showed diffuse 
hyperintensity in T2-weighted sections involving the white 
and gray matter indicating severe brain swelling (Fig 1A). 
Echocardiography disclosed hypertrophic cardiomyopathy. 
Abdominal ultrasonography was normal.
Despite steroid and mannitol therapy, the clinical course 
deteriorated with the appearance of frequent tonic and tonic- 
clonic seizures, swallowing difficulties, and recurrent pulmo­
nary infections. A second brain MRI, at 5 months of age, 
disclosed a generalized brain destruction with wide cavita­
tions (see Fig IB). He died 1 month later of cardiac failure.
At autopsy, there was a multicystic degeneration of all the 
supratencorial structures. There were no malformations or 
thromboembolism of the principal brain arteries. Light mi­
croscopy (see Fig 1C-F) showed diffuse small-vessel prolifer­
ation and gliosis of the brain; focal and symmetrical lesions 
were detected in the tegmentum and basis peduncles of mes­
encephalon, and randomly in the cerebellum. Heart showed 
hypertrophic cardiomyopathy with dilatation of the right 
ventricle. Light and electron microscopy of the heart showed 
pronounced mitochondrial proliferation. Biopsy o f the left 
quadriceps muscle showed mild mitochondrial proliferation
Patient 2
The oldest sibling o f Patient 1 was evaluated at another hos­
pital. He was born at term after an uneventful pregnancy.
Birth weight was 2,800 g (10th percentile), length 49 cm
(10th percentile), and head circumference 33 cm (10th per­
centile). At birth, muscle tone was normal, but sucking was 
weak. At 2 months o f age, hydrocephalus was suspected be­
cause of progressive increase of head circumference up to 
43.5 cm (above the 97th percentile) with bulking o f the an­
terior fontanel and patent sagittal fissure. He was extremely 
irritable and hypertonic. Brain computed tomographic scan­
ning showed ventriculomegaly and. diffuse supratentorial cor­
tical atrophy. Electrocardiography showed signs of biven­
tricular hypertrophy. Routine laboratory examinations were 
normal; lactate was not investigated. The child died at the 
age of 3 months. Autopsy showed diffuse brain destruction 
and hypertrophic cardiomyopathy.
Biochemical Studies
Lactate and pyruvate production and mitochondrial enzyme 
activities in fibroblasts [2, 3], enzymatic activities o f the re­
spiratory chain, pyruvate dehydrogenase complex, and citrate 
synthase from skeletal and heart muscle were measured as 
described previously [4, 5]. Heart tissue was obtained within 
3 hours after death and was frozen immediately in liquid 
nitrogen.
The protein composition of oxidative phosphorylation 
complexes was studied by Blue Native electrophoresis and 
sodium dodecyl sulfate (SDS) electrophoresis in the second 
dimension [61.
Results
The lactate and pyruvate production in fibroblasts after 
incubation with glucose showed an increased lactate/ 
pyruvate ratio (68; controls, 18 ±  10). This increased 
ratio, which reflects the cytosolic reduced/oxidized nic- 
otinamide-adenine dinucleotide phosphate (NADH/ 
NAD) redox state, suggested that the patient, indeed, 
suffered from a defect in the mitochondrial respiratory 
chain.
Enzyme activities, summarized in the Table, revealed 
a complex I deficiency in skeletal muscle, myocardium, 
and fibroblasts. The residual NADH:Q( reductase ac­
tivity was as low as 10% of the control mean in skeletal
Fig 1. (A and B) Brain magnetic resonance imaging T2-iveighted spin-echo axial sections o f Patient 1 at 2  months o f age (A) 
showing dijfiise hyperintensity o f the white matter and also o f temporal gray matter; at 5 months o f age (B) a massive brain de­
struction is evident. (C—E) Histopathology (hematoxylin—eosin) o f the occipital cortex (C, X50 before 20% reduction) showing dif­
fuse multicystic degeneration; focal lesions in the tegmentum o f mesencephalon (D, X 15 before 20% reduction) and cerebellum (E, 
X 12 before 20% reduction). A t higher magnification (inset, X200 before 20% reduction), characteristic changes showing pro­
nounced vasctdar proliferation and glyosis. (F) Schematic representation o f the distribution ofcentra.1 nervous system lesions (shaded
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Table. Enzyme Activities o f the Skeletal Muscle, Heart Muscle, and Fibroblasts from Patient 1
Skeletal Muscle Heart Muscle Fibroblasts
NADH:Q, oxidoreductase1 
Succinate:cytochrome c oxidoreductase1 
Decylubiquinol:cytochrome c oxidoreductase1 
Pyruvate dehydrogenase complex8 
Cytochrome c oxidase 
Citrate synthase
0.019 (0.200 ±  0.099) 
0.208 (0.234 ±  0.062) 
1.62 (1.82 ±  0.32) 
0.033 (0.040 ±  0.018) 
100 (94 ±  51)
168 (95 ±  34)
0.024 (0.220 ±  0.198)
0.200 (0.214 ±  0.085) 
1.30 (1.56 ±  0.56) 
0.014 (0.034 ±  0.015) 
122 (168 ±  143)
492  (302 ±  112)
0.026 (0.19 ±  0.05) 
0.21 (0.31 ±  0.06) 
1.70 (2.70 ±  0.41) 
N D
162 (182 ±  27)
149 (197 ±  42)
All activities were measured in a 600-g supernatant of the muscle homogenate, except for pyruvate dehydrogenase complex and citrate synthase, 
which were measured in total homogenate. Control mean ±  SD values are in parentheses.
“Expressed as milliunits per milliunk of cytochrome c oxidase.
Expressed as milliunits per milligram of protein.
N D  =  not determined.
and heart muscle, and 14% in cultured fibroblasts. The 
other enzymes showed normal activities, except for the 
pyruvate dehydrogenase complex in heart, which was 
in the low-normal range (42%). This reduction prob­
ably has been caused by the severe condition of the 
myocardium, pyruvate dehydrogenase complex being a 
sensitive, regulated enzyme complex.
A  specific reduction of the amount of complex I was 
demonstrated by two-dimensional (Native/SDS) elec­
trophoresis in skeletal muscle and in heart muscle (Fig 
2). Amounts and subunit compositions of complexes II 
to V  were normal.
Discussion
We have reported a new fatal phenotype with lactic 
acidosis, macrocephaly, hypertrophic cardiomyopathy, 
and a defect o f complex I of the mitochondrial respi­
ratory chain. The prominent feature o f this encepha­
lopathy was massive brain swelling causing macroceph­
aly and evolving to extensive brain destruction. It is 
noteworthy that this condition mostly involved the su- 
pratentorial brain structures. There were no inducing 
events, such as a febrile illness, and in both cases pro­
gressive macrocephaly began at the end of the first 
month of life.
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Fig 2. Two-dimensional resolution o f oxidative phos­
phorylation complexes from control skeletal muscle 
and control heart muscle, respectively (A and C), 
and skeletal muscle and heart muscle, respectively 
(B and D), from Patient 1 with complex I defi-
The characteristic complex I  protein subunits 
in the 25- to 75-kd range (marked by arrows) were 
not detectable in patient tissues. Oxidative phosphor­
ylation complexes from 10 mg (wet weight) o f skele­
tal muscle and 5  mg of heart muscle, respectively, 
were solubilized and separated in the native state by 
Blue Native electrophoresis. The subunits were re­
solved subsequently by sodium dodecyl sulfate—polyacryl­
amide gel electrophoresis (SDS-PAGE) in the second 
dimension and silver stained (A and B) or stained 
with Coomassie Blue dye (C and D).
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Infantile macrocephaly is a characteristic symptom of 
some metabolic diseases, such as Canavan’s disease, 
glutaric aciduria type 1, 3-hydroxy-3-methylglutaric 
aciduria, and L-2-hydroxyglutaric aciduria [7, 8]. How­
ever, all these disorders do not lead to massive brain 
destruction.
Severe cerebral edema is a typical finding of hyper- 
ammonemic coma in urea cycle defects [9]. In these 
disorders, brain edema is sustained by astrocyte swell­
ing due to the osmotic effect of accumulated glutamine 
[9]. Moreover, edema confined to cerebral and cerebel­
lar white matter, and basal ganglia is a distinctive fea­
ture of maple syrup urine disease [10].
Brain swelling and macrocephaly is exceptional in 
primary lactic acidosis. Neonatal macrocephaly and 
dysmorphism were observed in a patient with a defi­
ciency of the mitochondrial transport protein voltage- 
dependent anion channel [11]. Two siblings with fu- 
marase deficiency showed a severe neonatal encepha­
lopathy with macrocephaly and ventriculomegaly [12].
In pyruvate dehydrogenase deficiency, brain-destruc- 
tive changes appear to occur in the prenatal period and 
patients may present at birth with severe microceph­
aly, multiple cystic lesions, hydranencephaly, as well as 
developmental malformations [13].
The pathogenesis of generalized brain swelling in our 
patient with complex I deficiency remains to be clari­
fied. Focal brain swelling with midline shift has been 
established in MELAS patients [14]. Because the endo­
thelium of brain capillaries is rich in mitochondria, im­
pairment of oxidative phosphorylation in cerebral mi­
crovessels has been suggested to explain focal lesions in
MELAS [15] and, based on neuropathological findings,
can be assumed to be causal in our patients, although 
with a more wide distribution.
We conclude that a mitochondrial respiratory chain 
defect should be suspected in infants with generalized 
brain swelling progressing rapidly to massive destruc­
tion.
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